{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-093945","form_type":"8-K","ticker":"RYTM","cik":"0001649904","company_name":"RHYTHM PHARMACEUTICALS, INC.","filed_at":"2023-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.682945+00:00","generated_at":"2026-06-11T06:17:53.795402+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Rhythm Pharmaceuticals raises $50M via ATM equity offering of 2M shares","bullets":["Sold ~2.019M shares of common stock from Aug 10-21, 2023, for gross proceeds of ~$50M.","Proceeds, plus existing cash and anticipated $24.4M milestone from Healthcare Royalty Partners, fund operations into 2026.","Funds to support global commercialization of IMCIVREE (setmelanotide) and rare MC4R pathway clinical programs.","ATM program originally authorized up to $100M; this drawdown represents half the capacity."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-093945","json":"https://secwatch.observer/filing/0001104659-23-093945.json","markdown":"https://secwatch.observer/filing/0001104659-23-093945.md","text":"https://secwatch.observer/filing/0001104659-23-093945.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649904/000110465923093945/0001104659-23-093945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649904/000110465923093945/tm2324286d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T06:17:53.795402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}